Serina Therapeutics, Inc. (SER) valuation

Share price $1.94 · As of last filing 2026-03-31

Price-to-Earnings

P/E · Trailing Diluted

-0.97×

P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing

-1.59×

P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing

-62.85%

FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing

1.88×

EV/EBITDA history →

Underlying EBIT Margin

EBIT + SBC · Trailing

6173.85%

Methodology →

Price-to-Sales

P/S · Trailing

223.81×

P/S history →

Price-to-Book

P/B · Latest filing

2.29×

P/B history →

Special situation detected — historical normalisation may not reflect go-forward economics. EPV and Reverse-DCF outputs below are anchored on history that no longer represents the entity going forward (net cash > 50% of market cap) . Inspect the balance sheet, recent 8-K filings, and the cards above before relying on these models.

net cash > 50% of market cap. Net cash $21.2M (cash $24.5M − debt $3.3M) = 72.8% of market cap $29.1M

Related tickers

IDCC

INTERDIGITAL, INC.

RSI

Rush Street Interactive, Inc.

BBY

BEST BUY CO., INC.